Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perinatal Tissue Mesenchyme Stem Cells for Caesarean Section Scars
NCT02772289Phase 2Completed
- Sponsor
- Foshan Maternity & Child Healthcare Hospital
- Start
- Nov 2016
- Primary completion
- Sep 2018
- Modality
- Hydrogel Systems, Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of perinatal tissue mesenchymal stem cells in cicatrix (3 arms), sponsored by Foshan Maternity & Child Healthcare Hospital. Primary endpoint: Change of Vancouver Scar Scale at 6 months. Started Nov 2016; status: completed.
02
Drugs
perinatal tissue mesenchymal stem cells
03
Conditions
cicatrix
Beyond the preview
Go deeper on NCT02772289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02772289.